Serum PSA contains an additional α-(2,3)-linked sialic acid to the terminal galactose residue on N-linked oligosaccharides in prostate cancer when compared to healthy individuals [39, 44] (Figure 2). This evidence concerns the gene KLK3 and Familial prostate cancer.